Medtronic (BSP:MDTC34) Cyclically Adjusted Revenue per Share: R$68.07 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MDTC34 Medtronic PLC BSP:MDTC34
72 GF Score
Price R$213.98
GF Value R$247.66
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Cyclically Adjusted Revenue per Share?

Medtronic BSP:MDTC34 +0.27% 72 Cyclically Adjusted Revenue per Share is R$68.07 as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 72/100 and a GF Value™ of R$247.66 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medtronic's adjusted revenue per share for the three months ended in Apr. 2026 was R$19.167. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$68.07 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Medtronic's average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medtronic was 17.40% per year. The lowest was 4.20% per year. And the median was 9.10% per year.

As of today (2026-07-19), Medtronic's current stock price is R$213.98. Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 was R$68.07. Medtronic's Cyclically Adjusted PS Ratio of today is 3.14.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medtronic was 6.71. The lowest was 2.68. And the median was 4.81.


Medtronic  (BSP:MDTC34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medtronic's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=213.98/68.07
=3.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medtronic was 6.71. The lowest was 2.68. And the median was 4.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medtronic Cyclically Adjusted Revenue per Share Related Terms


Medtronic Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medtronic's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Cyclically Adjusted Revenue per Share Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.41 61.05 65.80 72.96 68.07

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.96 75.85 72.55 69.08 68.07

BSP:MDTC34 vs SYK, BSX, EW: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PS Ratio falls into.


BSP:MDTC34
72GF Score
Medtronic PLC BSP:MDTC34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medtronic's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=19.167/128.4300*128.4300
=19.167

Current CPI (Apr. 2026) = 128.4300.

Medtronic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 8.347 100.872 10.627
201610 8.401 99.776 10.814
201701 8.399 99.178 10.876
201704 8.993 100.773 11.461
201707 8.594 100.673 10.964
201710 8.239 100.374 10.542
201801 8.739 99.377 11.294
201804 10.161 100.374 13.001
201807 10.335 101.470 13.081
201810 10.338 101.271 13.110
201901 10.419 100.075 13.371
201904 11.746 102.068 14.780
201907 10.471 101.969 13.188
201910 11.640 101.969 14.661
202001 11.852 101.371 15.016
202004 11.813 101.969 14.879
202007 12.709 101.570 16.070
202010 15.907 100.474 20.333
202101 15.387 101.171 19.533
202104 16.789 103.065 20.921
202107 15.195 103.763 18.807
202110 16.043 105.557 19.519
202201 15.896 106.255 19.213
202204 14.309 110.242 16.670
202207 14.825 113.262 16.810
202210 14.954 115.315 16.655
202301 15.060 114.470 16.897
202304 16.097 118.213 17.488
202307 13.860 119.903 14.846
202310 15.154 121.111 16.070
202401 14.937 119.179 16.096
202404 16.645 121.232 17.633
202407 16.922 122.560 17.732
202410 18.374 121.956 19.349
202501 19.376 121.473 20.486
202504 20.070 123.888 20.806
202507 18.438 124.613 19.003
202510 18.726 125.410 19.177
202601 18.641 124.690 19.200
202604 19.167 128.430 19.167

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$68.07 mean?
Medtronic (BSP:MDTC34) has a Cyclically Adjusted Revenue per Share of R$68.07 as of Apr. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medtronic and its competitors.
Is Medtronic's Cyclically Adjusted Revenue per Share too high?
Medtronic's current Cyclically Adjusted Revenue per Share is R$68.07. Overall, Medtronic has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Cyclically Adjusted Revenue per Share compare to SYK and BSX?
Medtronic's Cyclically Adjusted Revenue per Share of R$68.07 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medtronic and its competitors. Medtronic's current Cyclically Adjusted Revenue per Share is R$68.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$247.66, compared to a current price of R$213.98 — trading 13.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$68.07. Medtronic's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Cyclically Adjusted Revenue per Share is R$68.07 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$213.98 is trading 13.6% below its estimated GF Value™ of R$247.66. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Cyclically Adjusted Revenue per Share: R$68.07
  • GF Value™: R$247.66 vs. price of R$213.98 (13.6% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
72GF Score

Get the complete analysis for BSP:MDTC34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$213.98
Price
R$247.66
GF Value